Your browser doesn't support javascript.
loading
Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index.
Pardo, María; Crujeiras, Ana B; Amil, María; Aguera, Zaida; Jiménez-Murcia, Susana; Baños, Rosa; Botella, Cristina; de la Torre, Rafael; Estivill, Xavier; Fagundo, Ana B; Fernández-Real, Jose M; Fernández-García, José C; Fruhbeck, Gema; Gómez-Ambrosi, Javier; Rodríguez, Roser; Tinahones, Francisco J; Fernández-Aranda, Fernando; Casanueva, Felipe F.
Afiliación
  • Pardo M; Laboratory of Molecular and Cellular Endocrinology, Health Research Institute of Santiago (IDIS), University Hospital of Santiago (XXIS/SERGAS) and Santiago de Compostela University (USC), 15706 Santiago de Compostela, Spain ; CIBER Fisiopatología de la Obesidad y la Nutrición (CIBERobn), 15706 Sant
  • Crujeiras AB; Laboratory of Molecular and Cellular Endocrinology, Health Research Institute of Santiago (IDIS), University Hospital of Santiago (XXIS/SERGAS) and Santiago de Compostela University (USC), 15706 Santiago de Compostela, Spain ; CIBER Fisiopatología de la Obesidad y la Nutrición (CIBERobn), 15706 Sant
  • Amil M; Laboratory of Molecular and Cellular Endocrinology, Health Research Institute of Santiago (IDIS), University Hospital of Santiago (XXIS/SERGAS) and Santiago de Compostela University (USC), 15706 Santiago de Compostela, Spain ; CIBER Fisiopatología de la Obesidad y la Nutrición (CIBERobn), 15706 Sant
  • Aguera Z; CIBER Fisiopatología de la Obesidad y la Nutrición (CIBERobn), 15706 Santiago de Compostela, Spain ; Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, 08907 Barcelona, Spain.
  • Jiménez-Murcia S; CIBER Fisiopatología de la Obesidad y la Nutrición (CIBERobn), 15706 Santiago de Compostela, Spain ; Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, 08907 Barcelona, Spain ; Department of Clinical Sciences, School of Medicine, University of Barcelona, 08007 Barcelona, Spain.
  • Baños R; CIBER Fisiopatología de la Obesidad y la Nutrición (CIBERobn), 15706 Santiago de Compostela, Spain ; Department of Psychological, Personality, Evaluation and Treatment of the University of Valencia, 46010 Valencia, Spain.
  • Botella C; CIBER Fisiopatología de la Obesidad y la Nutrición (CIBERobn), 15706 Santiago de Compostela, Spain ; Department of Basic Psychology, Clinic and Psychobiology of the Jaume I University, Castelló, 12071 Castelló de la Plana, Spain.
  • de la Torre R; CIBER Fisiopatología de la Obesidad y la Nutrición (CIBERobn), 15706 Santiago de Compostela, Spain ; Human Pharmacology and Clinical Neurosciences Research Group, Neuroscience Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
  • Estivill X; Center for Genomic Regulation (CRG), 08003 Barcelona, Spain ; Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública (CIBERESP), 08036 Barcelona, Spain.
  • Fagundo AB; CIBER Fisiopatología de la Obesidad y la Nutrición (CIBERobn), 15706 Santiago de Compostela, Spain ; Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, 08907 Barcelona, Spain.
  • Fernández-Real JM; CIBER Fisiopatología de la Obesidad y la Nutrición (CIBERobn), 15706 Santiago de Compostela, Spain ; Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomèdica de Girona (IdlBGi),Hospital Dr Josep Trueta, Girona, Spain.
  • Fernández-García JC; CIBER Fisiopatología de la Obesidad y la Nutrición (CIBERobn), 15706 Santiago de Compostela, Spain ; Department of Diabetes, Endocrinology and Nutrition, Hospital Cliínico Universitario Virgen de Victoria, 29010 Maálaga, Spain.
  • Fruhbeck G; CIBER Fisiopatología de la Obesidad y la Nutrición (CIBERobn), 15706 Santiago de Compostela, Spain ; Department of Endocrinology and Nutrition, University Clinic de Navarra, University of Navarra, 31008 Pamplona, Spain.
  • Gómez-Ambrosi J; CIBER Fisiopatología de la Obesidad y la Nutrición (CIBERobn), 15706 Santiago de Compostela, Spain ; Department of Endocrinology and Nutrition, University Clinic de Navarra, University of Navarra, 31008 Pamplona, Spain.
  • Rodríguez R; CIBER Fisiopatología de la Obesidad y la Nutrición (CIBERobn), 15706 Santiago de Compostela, Spain ; Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomèdica de Girona (IdlBGi),Hospital Dr Josep Trueta, Girona, Spain.
  • Tinahones FJ; CIBER Fisiopatología de la Obesidad y la Nutrición (CIBERobn), 15706 Santiago de Compostela, Spain ; Department of Diabetes, Endocrinology and Nutrition, Hospital Cliínico Universitario Virgen de Victoria, 29010 Maálaga, Spain.
  • Fernández-Aranda F; CIBER Fisiopatología de la Obesidad y la Nutrición (CIBERobn), 15706 Santiago de Compostela, Spain ; Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, 08907 Barcelona, Spain ; Department of Clinical Sciences, School of Medicine, University of Barcelona, 08007 Barcelona, Spain.
  • Casanueva FF; Laboratory of Molecular and Cellular Endocrinology, Health Research Institute of Santiago (IDIS), University Hospital of Santiago (XXIS/SERGAS) and Santiago de Compostela University (USC), 15706 Santiago de Compostela, Spain ; CIBER Fisiopatología de la Obesidad y la Nutrición (CIBERobn), 15706 Sant
Int J Endocrinol ; 2014: 857270, 2014.
Article en En | MEDLINE | ID: mdl-24864142
ABSTRACT
FNDC5/irisin has been recently postulated as beneficial in the treatment of obesity and diabetes because it is induced in muscle by exercise, increasing energy expenditure. However, recent reports have shown that WAT also secretes irisin and that circulating irisin is elevated in obese subjects. The aim of this study was to evaluate irisin levels in conditions of extreme BMI and its correlation with basal metabolism and daily activity. The study involved 145 female patients, including 96 with extreme BMIs (30 anorexic (AN) and 66 obese (OB)) and 49 healthy normal weight (NW). The plasma irisin levels were significantly elevated in the OB patients compared with the AN and NW patients. Irisin also correlated positively with body weight, BMI, and fat mass. The OB patients exhibited the highest REE and higher daily physical activity compared with the AN patients but lower activity compared with the NW patients. The irisin levels were inversely correlated with daily physical activity and directly correlated with REE. Fat mass contributed to most of the variability of the irisin plasma levels independently of the other studied parameters. Conclusion. Irisin levels are influenced by energy expenditure independently of daily physical activity but fat mass is the main contributing factor.

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Risk_factors_studies Idioma: En Revista: Int J Endocrinol Año: 2014 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Risk_factors_studies Idioma: En Revista: Int J Endocrinol Año: 2014 Tipo del documento: Article